The aim of this application is to develop a computer-based multimodal mind and body approach (CMMBA) for mild cognitive impairment (MCI). This product will provide a new, cost-effective and easily accessible treatment option for MCI and potentially other age-related dementia.
The goal of this Phase I R41 (STTR) application is to develop a computer-based multimodal mind and body approach (cbMMBA) to improve the cognitive function for mild cognitive impairment (MCI). This application, if successful, will provide a cost-effective and easily accessible treatment option for MCI and other age-related dementia, significantly improve the prevention of MCI development, and directly benefit patients suffering from the highly prevalent disorder, particularly for those who may have limited access to in-person mind and body interventions.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
32
cbMMBA will include three modules: BDJ, acupressure, and relaxation techniques including deep breathing, guided imagery, and progressive muscle relaxation.
The program uses paper puzzles (Sudoku, crosswords, word-search, etc.) to engage subjects
Massachusetts General Hospital
Charlestown, Massachusetts, United States
Retention
Proportion of subjects who complete all assessments from the total number of subjects started the first intervention
Time frame: Through study intervention, an average of three months
Fidelity
session completed of total 30 classes
Time frame: Through study interventions, an average of three months
Satisfaction to Intervention
average score in a 1-5 scale, 5 indicates very satisfied with the intervention
Time frame: Through study interventions, an average of three months
Number of Participants With Adverse Events
Adverse events were assessed by participant self-report at each study visit. An adverse event was defined as any unfavorable or unintended sign, symptom, or medical occurrence temporally associated with study participation, regardless of attribution. This outcome reports the number of participants who experienced ≥1 adverse event during the study period (each participant counted once).
Time frame: Through study interventions, an average of three months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.